EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cycling GLP-1 receptor agonist treatment induces therapeutic resistance and increased adiposity

Anna J Son, Emmanuel Rapp, Alex Wiezorek, Max G Leung, Ronadip R Banerjee, Thomas H Leung

JCI Insight · 22.05.2026 · 11 (10)

DOI: 10.1172/jci.insight.205174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, online erschienen am 31.03.2026. Verfasst von Anna J Son und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Adiposity, Obesity, Drug Resistance. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RRD VA, NIAMS NIH HHS, NIAMS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stopping and restarting GLP-1 weight-loss drugs in mice made them less effective over time and increased fat gain compared with continuous treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide-1 Receptor AgonistsAdiposityObesityDrug ResistanceAnimalsMiceGlucagon-Like Peptide-1 ReceptorHumansMaleHypoglycemic AgentsExenatideLiraglutideGlucagon-Like Peptide 1VenomsSemaglutide

Stichwörter der Autor:innen

Clinical practiceEndocrinologyMetabolismObesity

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide-1 ReceptorHypoglycemic AgentsExenatideLiraglutideGlucagon-Like Peptide 1VenomsSemaglutide

Autor:innen und Institutionen

  • Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Endocrinology, Department of Medicine, University of Arizona College of Medicine, Tucson, Arizona, USA.
  • Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.

Förderung

  • RRD VA
  • NIAMS NIH HHS
  • NIAMS
  • VA
  • NIH
  • Berstein Foundation
  • H.T. Leung Foundation

Zitieren

APA

Son, A. J., Rapp, E., Wiezorek, A., Leung, M. G., Banerjee, R. R., & Leung, T. H. (2026). Cycling GLP-1 receptor agonist treatment induces therapeutic resistance and increased adiposity. JCI Insight, 11(10). https://doi.org/10.1172/jci.insight.205174

Vancouver

Son AJ, Rapp E, Wiezorek A, Leung MG, Banerjee RR, Leung TH. Cycling GLP-1 receptor agonist treatment induces therapeutic resistance and increased adiposity. JCI Insight. 2026;11(10). doi:10.1172/jci.insight.205174

BibTeX
@article{Son2026,
  author = {Son, Anna J and Rapp, Emmanuel and Wiezorek, Alex and Leung, Max G and Banerjee, Ronadip R and Leung, Thomas H},
  title = {Cycling GLP-1 receptor agonist treatment induces therapeutic resistance and increased adiposity},
  journal = {JCI Insight},
  year = {2026},
  volume = {11},
  number = {10},
  doi = {10.1172/jci.insight.205174}
}
Kostenlos starten →